S 2062
RAPID Reserve Act
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 8:46 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
The RAPID Reserve Act aims to strengthen the U.S. drug supply chain by creating a system for establishing and maintaining reserves of critical drugs and their active pharmaceutical ingredients. The Secretary of Health and Human Services will award contracts to eligible entities – manufacturers, distributors, or wholesalers – to hold these reserves, ensuring a supply during shortages or public health emergencies. The bill also encourages domestic manufacturing and provides guidance on selecting vulnerable drugs and evaluating potential participants in the program, with an initial appropriation of $500 million for fiscal year 2026.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.